Pulmatrix Inc (PULM)
1.90
0.00 (0.00%)
USD |
NASDAQ |
May 01, 10:02
Pulmatrix Price to Book Value: 0.3856 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 0.3856 |
| April 29, 2024 | 0.3856 |
| April 26, 2024 | 0.414 |
| April 25, 2024 | 0.4222 |
| April 24, 2024 | 0.41 |
| April 23, 2024 | 0.41 |
| April 22, 2024 | 0.409 |
| April 19, 2024 | 0.4038 |
| April 18, 2024 | 0.3978 |
| April 17, 2024 | 0.4242 |
| April 16, 2024 | 0.4303 |
| April 15, 2024 | 0.4242 |
| April 12, 2024 | 0.4384 |
| April 11, 2024 | 0.4262 |
| April 10, 2024 | 0.3856 |
| April 09, 2024 | 0.3877 |
| April 08, 2024 | 0.3836 |
| April 05, 2024 | 0.4078 |
| April 04, 2024 | 0.3812 |
| April 03, 2024 | 0.3674 |
| April 02, 2024 | 0.3471 |
| April 01, 2024 | 0.3532 |
| March 28, 2024 | 0.3552 |
| March 27, 2024 | 0.3288 |
| March 26, 2024 | 0.3431 |
| Date | Value |
|---|---|
| March 25, 2024 | 0.3389 |
| March 22, 2024 | 0.3389 |
| March 21, 2024 | 0.3329 |
| March 20, 2024 | 0.3344 |
| March 19, 2024 | 0.3288 |
| March 18, 2024 | 0.3308 |
| March 15, 2024 | 0.341 |
| March 14, 2024 | 0.3542 |
| March 13, 2024 | 0.3511 |
| March 12, 2024 | 0.3613 |
| March 11, 2024 | 0.3755 |
| March 08, 2024 | 0.3877 |
| March 07, 2024 | 0.4019 |
| March 06, 2024 | 0.3856 |
| March 05, 2024 | 0.3856 |
| March 04, 2024 | 0.3797 |
| March 01, 2024 | 0.3887 |
| February 29, 2024 | 0.4039 |
| February 28, 2024 | 0.408 |
| February 27, 2024 | 0.4161 |
| February 26, 2024 | 0.3958 |
| February 23, 2024 | 0.3958 |
| February 22, 2024 | 0.3653 |
| February 21, 2024 | 0.3633 |
| February 20, 2024 | 0.3603 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3058
Minimum
Sep 27 2022
7.220
Maximum
Jun 22 2020
1.274
Average
0.8525
Median
May 12 2021
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 1.765 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.6251 |
| Theriva Biologics Inc | 0.1809 |
| Oragenics Inc | 2.944 |
Price to Book Value Related Metrics
| PS Ratio | 0.9507 |
| Price | 1.90 |
| Earnings Yield | -203.2% |
| Market Cap | 6.939M |